Abstract
The surprising ability of thalidomide and its analogs to treat various hematologic malignancies is through the loss of two transcription factors.
Original language | English (US) |
---|---|
Pages (from-to) | 256-257 |
Number of pages | 2 |
Journal | Science |
Volume | 343 |
Issue number | 6168 |
DOIs | |
State | Published - 2014 |
ASJC Scopus subject areas
- General